ZL-1311
/ ZAI Lab
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 06, 2026
Anticipated Major Milestones:…ZL-1311 (MUC17/CD3)
(Businesswire)
- "Submit an IND application in the U.S. by year-end 2026 and initiate a global Phase 1 study in the first half of 2027."
IND • New P1 trial • Oncology
1 to 1
Of
1
Go to page
1